Cited 53 times in
Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김동석 | - |
dc.contributor.author | 이영훈 | - |
dc.contributor.author | 정병하 | - |
dc.contributor.author | 조강수 | - |
dc.contributor.author | 조남훈 | - |
dc.contributor.author | 홍성준 | - |
dc.date.accessioned | 2015-04-23T16:30:07Z | - |
dc.date.available | 2015-04-23T16:30:07Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 0090-4295 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/100699 | - |
dc.description.abstract | OBJECTIVES: To investigate the prognostic significance of lymphovascular invasion (LVI) in patients with localized upper urinary tract transitional cell carcinoma (UUT-TCC) after radical nephroureterectomy. METHODS: The clinical records of 271 patients with UUT-TCC who underwent radical nephroureterectomy between 1986 and 2006 were reviewed. Patients with pT4 stage, lymph node involvement, or distant metastasis were excluded. A total of 238 patients with pTa-3N0M0 were eligible. The prognostic significance of various clinicopathologic factors was analyzed using univariate and multivariate analysis. The mean age was 64.1 years (range, 25-91 years) and the median follow-up duration was 53.4 months (range, 3-240 months). RESULTS: LVI was present in 31 patients (13%). LVI was related to higher pT stage, high tumor grade, sessile architecture, and squamous differentiation. On univariate analysis, tumor architecture, squamous differentiation, LVI, tumor grade, and pT stage influenced disease-specific survival. On multivariate analysis, LVI (hazards ratio [HR], 2.33; P = .014) and pT stage (HR, 2.07; P = .021) showed significantly different rates of disease-specific survival. Patients were classified according to pT stage and LVI. The high-risk group (pT3 and LVI+) showed significantly worse disease-specific survival than the low- (pT < or = 2 and LVI-) or intermediate-risk groups (pT3 and LVI-, pT < or = 2 and LVI+) (P <.001 and P = .032, respectively). CONCLUSIONS: LVI and pT stage are significant prognostic factors for recurrence-free and cancer-specific survivals in patients with localized UUT-TCC. LVI and pT stage would be helpful for selecting patients who are appropriate for postoperative adjuvant chemotherapy | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 328~332 | - |
dc.relation.isPartOf | UROLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Adult | - |
dc.subject.MESH | Aged | - |
dc.subject.MESH | Aged, 80 and over | - |
dc.subject.MESH | Carcinoma, Transitional Cell/mortality | - |
dc.subject.MESH | Carcinoma, Transitional Cell/pathology* | - |
dc.subject.MESH | Carcinoma, Transitional Cell/surgery* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Kidney Neoplasms/mortality | - |
dc.subject.MESH | Kidney Neoplasms/pathology* | - |
dc.subject.MESH | Kidney Neoplasms/surgery* | - |
dc.subject.MESH | Kidney Pelvis* | - |
dc.subject.MESH | Lymphatic Metastasis | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Middle Aged | - |
dc.subject.MESH | Neoplasm Invasiveness | - |
dc.subject.MESH | Neoplasm Staging | - |
dc.subject.MESH | Nephrectomy*/methods | - |
dc.subject.MESH | Prognosis | - |
dc.subject.MESH | Survival Rate | - |
dc.subject.MESH | Ureter/surgery* | - |
dc.subject.MESH | Ureteral Neoplasms/mortality | - |
dc.subject.MESH | Ureteral Neoplasms/pathology* | - |
dc.subject.MESH | Ureteral Neoplasms/surgery* | - |
dc.subject.MESH | Vascular Neoplasms/pathology* | - |
dc.title | Lymphovascular invasion and pT stage are prognostic factors in patients treated with radical nephroureterectomy for localized upper urinary tract transitional cell carcinoma | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Urology (비뇨기과학) | - |
dc.contributor.googleauthor | Dong Suk Kim | - |
dc.contributor.googleauthor | Young Hoon Lee | - |
dc.contributor.googleauthor | Kang Su Cho | - |
dc.contributor.googleauthor | Nam Hoon Cho | - |
dc.contributor.googleauthor | Byung Ha Chung | - |
dc.contributor.googleauthor | Sung Joon Hong | - |
dc.identifier.doi | 10.1016/j.urology.2009.07.1350 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00403 | - |
dc.contributor.localId | A02969 | - |
dc.contributor.localId | A03607 | - |
dc.contributor.localId | A03801 | - |
dc.contributor.localId | A03812 | - |
dc.contributor.localId | A04402 | - |
dc.relation.journalcode | J02775 | - |
dc.identifier.eissn | 1527-9995 | - |
dc.identifier.pmid | 20018349 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0090429509026004 | - |
dc.contributor.alternativeName | Kim, Dong Suk | - |
dc.contributor.alternativeName | Lee, Young Hoon | - |
dc.contributor.alternativeName | Chung, Byung Ha | - |
dc.contributor.alternativeName | Cho, Kang Su | - |
dc.contributor.alternativeName | Cho, Nam Hoon | - |
dc.contributor.alternativeName | Hong, Sung Joon | - |
dc.contributor.affiliatedAuthor | Kim, Dong Suk | - |
dc.contributor.affiliatedAuthor | Lee, Young Hoon | - |
dc.contributor.affiliatedAuthor | Chung, Byung Ha | - |
dc.contributor.affiliatedAuthor | Cho, Kang Su | - |
dc.contributor.affiliatedAuthor | Cho, Nam Hoon | - |
dc.contributor.affiliatedAuthor | Hong, Sung Joon | - |
dc.citation.volume | 75 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 328 | - |
dc.citation.endPage | 332 | - |
dc.identifier.bibliographicCitation | UROLOGY, Vol.75(2) : 328-332, 2010 | - |
dc.identifier.rimsid | 37756 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.